Overview
BioNTech is a biopharmaceutical company focused on developing active immunotherapies for patient-specific approaches to the treatment of diseases. The company leverages its expertise in mRNA technology and immunotherapy to develop cancer immunotherapies, infectious disease vaccines, and other therapeutic modalities. BioNTech's architecture centers around mRNA design, formulation, and delivery, enabling rapid development and scalable manufacturing. The company's value proposition lies in its ability to create personalized cancer vaccines and address unmet medical needs in infectious diseases. Use cases include developing vaccines against COVID-19, creating individualized cancer immunotherapies, and advancing novel immunomodulators to enhance anti-tumor responses.